Insider Profile
Lockhard, Peter Douglas
$RX
1
Companies Filed At
24
Open-Market Buys (2yr)
$77K
Buy Value (2yr, open-market)
Jun 30, 2026
Most Recent Trade
Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days
$RX 63
BioSyent Inc.
$39K · 9 buys
Last buy Jun 22, 2026
Date Company Role Nature Dir. Shares Price Value Score
Jun 30, 2026 $RX
BioSyent Inc.
— Exercise Sell 1,493 — — 63
Jun 30, 2026 $RX
BioSyent Inc.
— Exercise Buy 746 $14.50 $11K 63
Jun 22, 2026 $RX
BioSyent Inc.
— Open Market Buy 74 $14.00 $1K 63
Jun 18, 2026 $RX
BioSyent Inc.
— Open Market Buy 600 $14.00 $8K 63
Jun 11, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $14.00 $4K 63
Jun 11, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $14.10 $4K 63
Jun 10, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $14.00 $4K 63
Jun 10, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $13.90 $4K 63
May 26, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $14.10 $4K 63
May 26, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $14.00 $4K 63
May 26, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $13.85 $4K 63
May 25, 2026 $RX
BioSyent Inc.
— Open Market Buy 300 $13.75 $4K 63
Mar 31, 2026 $RX
BioSyent Inc.
— Exercise Buy 742 $14.42 $11K 63
Mar 31, 2026 $RX
BioSyent Inc.
— Exercise Sell 1,484 — — 63
Mar 30, 2026 $RX
BioSyent Inc.
— Open Market Buy 100 $14.70 $1K 63
Mar 26, 2026 $RX
BioSyent Inc.
— Open Market Buy 100 $14.70 $1K 63
Mar 26, 2026 $RX
BioSyent Inc.
— Open Market Buy 100 $14.75 $1K 63
Mar 26, 2026 $RX
BioSyent Inc.
— Open Market Buy 100 $14.70 $1K 63
Mar 24, 2026 $RX
BioSyent Inc.
— Comp. Grant Buy 3,600 — — 63
Dec 31, 2025 $RX
BioSyent Inc.
— Exercise Sell 1,142 — — 63
Dec 31, 2025 $RX
BioSyent Inc.
— Exercise Buy 571 $12.73 $7K 63
Dec 31, 2025 $RX
BioSyent Inc.
— Plan / DRIP Buy 291 $11.76 $3K 63
Sep 30, 2025 $RX
BioSyent Inc.
— Exercise Buy 568 $11.54 $7K 63
Sep 30, 2025 $RX
BioSyent Inc.
— Exercise Sell 1,137 — — 63
May 23, 2025 $RX
BioSyent Inc.
— Open Market Buy 63 $11.93 $752 63
May 23, 2025 $RX
BioSyent Inc.
— Open Market Buy 100 $11.85 $1K 63
May 23, 2025 $RX
BioSyent Inc.
— Open Market Buy 200 $11.95 $2K 63
May 22, 2025 $RX
BioSyent Inc.
— Open Market Buy 200 $11.75 $2K 63
Mar 31, 2025 $RX
BioSyent Inc.
— Exercise Buy 563 $11.15 $6K 63
Mar 31, 2025 $RX
BioSyent Inc.
— Exercise Sell 1,127 — — 63
Mar 21, 2025 $RX
BioSyent Inc.
— Open Market Buy 40 $11.25 $450 63
Mar 19, 2025 $RX
BioSyent Inc.
— Open Market Buy 500 $11.25 $6K 63
Mar 18, 2025 $RX
BioSyent Inc.
— Comp. Grant Buy 4,200 — — 63
Mar 18, 2025 $RX
BioSyent Inc.
— Open Market Buy 100 $11.25 $1K 63
Dec 31, 2024 $RX
BioSyent Inc.
— Exercise Buy 640 $11.00 $7K 63
Dec 31, 2024 $RX
BioSyent Inc.
— Plan / DRIP Buy 309 $8.94 $3K 63
Dec 31, 2024 $RX
BioSyent Inc.
— Exercise Buy 1,281 — — 63
Nov 25, 2024 $RX
BioSyent Inc.
— Open Market Buy 637 $11.45 $7K 63
Sep 30, 2024 $RX
BioSyent Inc.
— Exercise Sell 1,275 — — 63
Sep 30, 2024 $RX
BioSyent Inc.
— Exercise Buy 637 $10.71 $7K 63
Sep 23, 2024 $RX
BioSyent Inc.
— Open Market Buy 600 $11.10 $7K 63
Sep 23, 2024 $RX
BioSyent Inc.
— Open Market Buy 35 $11.15 $390 63
Jul 02, 2024 $RX
BioSyent Inc.
— Exercise Buy 635 $10.00 $6K 63
Jul 02, 2024 $RX
BioSyent Inc.
— Exercise Sell 1,270 — — 63
Apr 01, 2024 $RX
BioSyent Inc.
— Exercise Sell 1,264 — — 63
Apr 01, 2024 $RX
BioSyent Inc.
— Exercise Buy 632 $8.69 $5K 63
Mar 28, 2024 $RX
BioSyent Inc.
— Open Market Buy 556 $8.70 $5K 63
Mar 27, 2024 $RX
BioSyent Inc.
— Comp. Grant Buy 5,173 — — 63
Mar 26, 2024 $RX
BioSyent Inc.
— Open Market Buy 600 $8.70 $5K 63
Mar 15, 2024 $RX
BioSyent Inc.
— Plan / DRIP Buy 403 $7.64 $3K 63
Jan 02, 2024 $RX
BioSyent Inc.
— Exercise Sell 2,313 — — 63
Jan 02, 2024 $RX
BioSyent Inc.
— Exercise Buy 1,156 $8.95 $10K 63
Oct 02, 2023 $RX
BioSyent Inc.
— Exercise Sell 2,297 — — 63
Oct 02, 2023 $RX
BioSyent Inc.
— Exercise Buy 1,148 $7.86 $9K 63
Jun 30, 2023 $RX
BioSyent Inc.
— Exercise Buy 2,289 — — 63
Jun 30, 2023 $RX
BioSyent Inc.
— Exercise Buy 1,144 $7.49 $9K 63
Mar 31, 2023 $RX
BioSyent Inc.
— Comp. Grant Buy 5,633 — — 63
Mar 31, 2023 $RX
BioSyent Inc.
— Exercise Sell 2,277 — — 63
Mar 31, 2023 $RX
BioSyent Inc.
— Exercise Buy 1,138 — — 63
Dec 31, 2022 $RX
BioSyent Inc.
— Plan / DRIP Buy 103 $7.06 $727 63
Mar 31, 2022 $RX
BioSyent Inc.
— Comp. Grant Buy 4,292 — — 63
Mar 19, 2021 $RX
BioSyent Inc.
— Comp. Grant Buy 4,897 — — 63
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.